JSA/WAO Joint Congress 2020

Session information

Poster Session

Dermatology

[PE10] Poster Session 10
Atopic dermatitis 2

Naoko Kanda1, Michiko Ito2, Takashi Morita1, Shizuka Okazaki1, Mototaka Koto1, Yuri Ichikawa1, Ryoko Takayama2, Toshihiko Hoashi2, Hidehisa Saeki2 (1.Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Japan, 2.Department of Dermatology, Nippon Medical School, Japan)

Sakae Kaneko1, Takeshi Nakahara2, Hiroyuki Murota3, Akio Tanaka4, Yoko Kataoka5, Takeyasu Kakamu6, Norito Kato7 (1.Department of Dermatology, Shimane University Faculty of Medicine, Japan, 2.Division of Skin Surface Sensing, Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Japan, 3.Department of Dermatology, Nagasaki University Graduate School of Medicine, Japan, 4.Department of Dermatology, Graduate school of Biomedical & Health Sciences, Hiroshima University, Japan, 5.Department of Dermatology, Osaka Habikino Medical Center, Japan, 6.Department of Hygiene & Preventive Medicine, Fukushima Medical University School of Medicin, Japan, 7.Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan)

Satoshi Yamada1, Yutaka Nishida1, Shun Takahashi1, Naoya Arakawa1, Toru Uchida1, Koichiro Sato2, Satomi Hagiwara1,3, Hisako Yagi1, Hirokazu Arakawa1, Takumi Takizawa1 (1.Department of Pediatrics, Gunma University Graduate School of Medicine, Japan, 2.Department of Pediatrics, Takasaki General Medical Center, Japan, 3.Shigeta Child Allergy Clinic, Japan)

Joo Young Roh1, Young Lip Park2, Chun Wook Park3, Zhen Chen4, Arima Kazuhiko5, Oh EunSil6, Brad Shumel4, Ana B Rossi7 (1.Gachon University, Gil Medical Center, Republic of Korea, 2.Soonchunhyang University, College of Medicine, Republic of Korea, 3.Hallym University, College of Medicine, Republic of Korea, 4.Regeneron Pharmaceuticals, Inc., USA, 5.Sanofi K.K., Japan, 6.Sanofi-aventis, Republic of Korea, 7.Sanofi Genzyme, USA)

Yoko Murakami1, Masaaki Kawano1, Daisuke Yasunari1, Takeshi Oki1, Koki Okabe1, Kento Fukushima1, Mihoko Iwata1, Masatoshi Wakatsuki1, Naohiko Taba1, Hiroshi Matsuzaki1, Chikako Motomura1, Satoshi Honjyo1,2, Akiko Sugiyama1,2, Hiroshi Odajima1 (1.Department of Pediatrics, National Hospital Organization Fukuoka Nartional Hospital, Japan, 2.Department of Dermatology, National Hospital Organization Fukuoka National Hospital, Japan)

Kazumasa Kamei1, Hidehisa Saeki2, Takanori Tsuchiya1, Tomohiro Hirose1, Eduardo Kawasaki1, Fumihiro Matsumoto1, Noritoshi Yoshii1, Shinichi Imafuku3 (1.Pfizer Japan Inc., Japan, 2.Department of Dermatology, Nippon Medical School, Japan, 3.Dermatology, Fukuoka University, Japan)

Marjolein De Bruin-Weller1, Eric L Simpson2, Amy S Paller3, Elaine C Siegfried4,5, Jonathan Corren6, Zhen Chen7, Ana B Rossi8, Kazuhiko Arima9, Faisal A Khokhar7, Ashish Bansal7 (1.University Medical Center, The Netherlands, 2.Oregon Health & Science University, USA, 3.Northwestern University Feinberg School of Medicine, USA, 4.Saint Louis University, USA, 5.Cardinal Glennon Children's Hospital, USA, 6.David Geffen School of Medicine at UCLA, USA, 7.Regeneron Pharmaceuticals, Inc., USA, 8.Sanofi Genzyme, USA, 9.Sanofi K.K., Japan)